This inventor holds 1 USPTO granted patent and 8 published patent applications and 1 EPO patent. Top assignee: Yunbaiyao Zhengwu Science and Technology (Shanghai) Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Xinyi Wang: Innovator in Cancer Treatment
Introduction
Xinyi Wang is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for cancer treatment. Her work exemplifies the intersection of science and technology in addressing critical health challenges.
Latest Patents
Xinyi Wang holds a patent for an imidazotriazine thiobenzamide derivative, which is a novel compound with potential applications in cancer therapy. The patent details a preparation method for this derivative and outlines its use in the development of drugs aimed at treating cancer. This innovative approach highlights her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout her career, Xinyi Wang has demonstrated exceptional expertise in medicinal chemistry and drug development. Her work at Yunbaiyao Zhengwu Science and Technology (Shanghai) Co., Ltd. has positioned her as a key player in the pharmaceutical industry. With a focus on creating effective treatments, she continues to push the boundaries of what is possible in cancer research.
Collaborations
Xinyi Wang collaborates with talented professionals in her field, including Zhengwu Shen and Bin Deng. These partnerships enhance her research efforts and contribute to the successful development of innovative therapies.
Conclusion
Xinyi Wang's contributions to cancer treatment through her patented innovations reflect her dedication to improving healthcare. Her work not only advances scientific knowledge but also holds the promise of better treatment options for patients facing cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile